Sugi Predict

Sugi Predict / Compounds / SCHEMBL30152284

SCHEMBL30152284

SCHEMBL30152284

CC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CSSC[C@@H](C(=O)NC(C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)NCC(N)=O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC1=O

nearest known ligand 0.63

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PRLHR P49683 9/20 0.63
▸ NPY2R P49146 9/20 0.61
▸ NPFFR2 Q9Y5X5 1/20 0.58
▸ GLP1R P43220 2/20 0.57
▸ GCGR P47871 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29461365 0.88 KLK5 (0.57) PRLHRNPY2RGLP1R
Somatostatin Receptor Ligand SCHEMBL8814211 0.76 PRLHR (0.67) PRLHRNPY2RNPFFR2
SCHEMBL29964142 0.76 F11 (0.56) PRLHRGLP1RGCGR
SCHEMBL24725780 0.76 MC4R (0.61) NPY2R
SCHEMBL25084074 0.76 MC4R (0.61) PRLHRNPY2R
SCHEMBL26952437 0.75 MC4R (0.59) NPY2RGLP1RGCGR
SCHEMBL25083695 0.75 MC4R (0.64) PRLHRNPY2R
SCHEMBL30888738 0.75 NPY2R (0.63) NPY2R
SCHEMBL24255998 0.75 MC4R (0.67) PRLHRNPY2R
SCHEMBL26899258 0.75 MC4R (0.67) PRLHRNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119669484-A Knowledge graph link prediction method, device, equipment and medium 中国人民解放军国防科技大学 2025-03-21 — — CN disclosed
US-20250009896-A1 SUPRAMOLECULAR FILAMENTS BASED VIRAL PARTICLE CAPTURE FOR PREVENTION AND THERAPY OF VIRAL INFECTION THE JOHNS HOPKINS UNIVERSITY 2025-01-09 — — US disclosed
EP-4135660-A1 COMPOSITIONS AND METHODS TO REDUCE THE INFECTIVITY OF A VIRUS Atossa Therapeutics, Inc. (US) 2023-02-22 — — EP disclosed
EP-4132964-A2 DE NOVO PROTEIN DECOYS OF ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) Neoleukin Therapeutics, Inc. (US) 2023-02-15 — — EP disclosed
CN-115515972-A De novo protein decoys for angiotensin converting enzyme 2 (ACE 2) 尼尔路金治疗公司 2022-12-23 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009896-A1 SUPRAMOLECULAR FILAMENTS BASED VIRAL PARTICLE CAPTURE FOR PREVENTION AND THERAPY OF VIRAL INFECTION ACE2, ACE, MASP2 PRLHR 4477/4885NPY2R 1530/4885NPFFR2 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.